                         SEQUENCE LISTING

<110>  ACEA THERAPEUTICS, INC.
 
<120>  PROTEASE INHIBITORS AS ANTIVIRALS

<130>  01223-0112-00PCT

<140>  PCT/US2022/031815
<141>  2022-06-01

<150>  US 63/195,930
<151>  2021-06-02

<150>  US 63/275,113
<151>  2021-11-03

<160>  2     

<170>  PatentIn version 3.5

<210>  1
<211>  14
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  FRET peptide substrate


<220>
<221>  MISC_FEATURE
<222>  (1)..(1)
<223>  DABCYL at N-terminus

<220>
<221>  MISC_FEATURE
<222>  (14)..(14)
<223>  EDANS at C-terminus

<400>  1

Lys Thr Ser Ala Val Leu Gln Ser Gly Phe Arg Lys Met Glu 
1               5                   10                  


<210>  2
<211>  7
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Fluorescent product


<220>
<221>  MISC_FEATURE
<222>  (7)..(7)
<223>  EDANS at C-terminus

<400>  2

Ser Gly Phe Arg Lys Met Glu 
1               5           


